Oric Pharmaceuticals Inc (ORIC)
R&D Expense Growth
-3.73%
Fiscal year · Period ending:
ORIC R&D Expense Growth
Latest reported-3.73%period ending
Latest reported-3.73%period ending
ORIC FY R&D Growth (YoY) (0.00% → -3.73%)
Latest values, visible window
High-resolution chart · PNG
ORIC r&d expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| -3.7292% | |
| 33.9313% | |
| 38.0869% | |
| 8.4808% | |
| -6.4281% | |
| 165.9954% | |
| 20.0673% | |
| -0.5228% | |
| 0% |